| scholarly article | Q13442814 |
| MDMA | Q69488 |
| P6179 | Dimensions Publication ID | 1049506342 |
| P356 | DOI | 10.1186/1742-2094-8-165 |
| P932 | PMC publication ID | 3283542 |
| P698 | PubMed publication ID | 22114930 |
| P5875 | ResearchGate publication ID | 51828311 |
| P2093 | author name string | Esther O'Shea | |
| Andrea Mayado | |||
| Elisa Torres | |||
| Maria D Gutierrez-Lopez | |||
| Maria I Colado | |||
| P2860 | cites work | The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). | Q48374881 |
| Region-specific induction of hypoxic tolerance by expression of stress proteins and antioxidant enzymes | Q48545405 | ||
| Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat. | Q48687973 | ||
| Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("Ecstasy"). | Q48824498 | ||
| Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons | Q48882811 | ||
| ALTERATIONS IN LYSOSOMES (INTRACELLULAR ENZYMES) DURING SHOCK; EFFECTS OF PRECONDITIONING (TOLERANCE) AND PROTECTIVE DRUGS | Q50268727 | ||
| Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats | Q71694668 | ||
| The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia | Q72572629 | ||
| Modulation of the acute phase response by altered expression of the IL-1 type 1 receptor or IL-1ra | Q73630790 | ||
| Interleukin-1 | Q74629939 | ||
| Protein measurement with the Folin phenol reagent | Q20900776 | ||
| Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex | Q24321703 | ||
| Potentiation of the T-lymphocyte response to mitogens. I. The responding cell | Q24679275 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat | Q28189196 | ||
| Cytokines and acute neurodegeneration | Q28190084 | ||
| Evidence that MDMA ('ecstasy') increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain | Q28564583 | ||
| 3,4-Methylenedioxymethamphetamine increases pro-interleukin-1beta production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: role of interleukin-1beta in neurotoxicity | Q28568813 | ||
| Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression | Q32024563 | ||
| The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). | Q34215236 | ||
| Endogenous interleukin-1 receptor antagonist is neuroprotective | Q34427502 | ||
| Ischemic tolerance and endogenous neuroprotection | Q35126696 | ||
| A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response | Q35908473 | ||
| Molecular physiology of preconditioning-induced brain tolerance to ischemia | Q37056974 | ||
| Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro | Q37126896 | ||
| Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain | Q37368451 | ||
| MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature | Q38758177 | ||
| Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats | Q40365875 | ||
| A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons | Q40379051 | ||
| 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion | Q40532235 | ||
| The two interleukin-1 receptors play different roles in IL-1 actions. | Q40666059 | ||
| Central action sites of interleukin-1 beta for inducing fever in rabbits | Q40758941 | ||
| Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity | Q41885785 | ||
| Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex. | Q41954356 | ||
| Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration | Q42008895 | ||
| Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischaemia in the cerebral cortex of the rat. | Q42015751 | ||
| In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine | Q42261569 | ||
| Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. | Q42489289 | ||
| Activation of the nuclear factor-kappaB is a key event in brain tolerance. | Q43653405 | ||
| Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia. | Q44524201 | ||
| ‘Ischemic tolerance’ phenomenon detected in various brain regions | Q44805794 | ||
| Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones | Q45053012 | ||
| (+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane | Q46529137 | ||
| Kainic acid-induced oxidative injury is attenuated by hypoxic preconditioning | Q46555128 | ||
| Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain | Q46580669 | ||
| Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist. | Q46910077 | ||
| Endotoxin preconditioning protects neurones from in vitro ischemia: role of endogenous IL-1beta and TNF-alpha | Q46913266 | ||
| Evidence for a role of Hsp70 in the neuroprotection induced by heat shock pre-treatment against 3,4-methylenedioxymethamphetamine toxicity in rat brain | Q48258439 | ||
| P921 | main subject | neurotoxicity | Q3338704 |
| P304 | page(s) | 165 | |
| P577 | publication date | 2011-11-24 | |
| P1433 | published in | Journal of Neuroinflammation | Q15716679 |
| P1476 | title | Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA. | |
| P478 | volume | 8 |
| Q58112081 | Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation? |
| Q36612395 | IL-1RAcPb signaling regulates adaptive mechanisms in neurons that promote their long-term survival following excitotoxic insults |
| Q64103344 | Increased iNOS and Nitrosative Stress in Dopaminergic Neurons of MDMA-Exposed Rats |
| Q28389929 | Interleukin 1 receptor contributes to methamphetamine- and sleep deprivation-induced hypersomnolence |
| Q37052573 | Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1β mRNA expression in the hypothalamus. |
Search more.